MARIA TERESA GUILLERMO: Open Payments
NPI 1679210439 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 36 payments from 20 companies in 2025. Trend: 2023 $90 · 2024 $503 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $149 |
| Otsuka America Pharmaceutical, Inc. | 3 | $80 |
| Corcept Therapeutics | 1 | $61 |
| Dexcom, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $43 |
| PFIZER INC. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| Verity Pharmaceuticals Inc. | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
Products named: REXULTI, Wegovy, Korlym, Dexcom G6 Transmitter, SHINGRIX, Ozempic, KRYSTEXXA, Tlando.
Industry payments across TX — which companies pay providers there.
